Skip to main content

Advertisement

Table 3 Capitalized expected costs and capitalized cost per approved drug

From: Estimating the clinical cost of drug development for orphan versus non-orphan drugs

Drug Type Phase Mean phase length (days) Capitalized expected clinical costs (in millions of 2013 USD) Capitalized clinical cost per approved drug (in millions of 2013 USD)
Non-orphan 1 624 $4.6 $412.4
2 849 $10.0
3 771 $28.5
Total $43.1
Orphan 1 1198 $8.8 $291.3
2 1463 $40.5
3 1506 $46.6
Total $95.9